SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
International Stem Cell CORP
@ISCO_InsiderForm 4 Filing: MAIER PAUL V Acquires (Grant) shares of $ISCO
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
International Stem Cell CORP
Ticker: $ISCO
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-11
Shares: 212,584
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MAIER PAUL V, holds the title of Director at International Stem Cell CORP.
On 2026-06-11, the insider transacted 212,584 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
MAIER PAUL V (Director) was granted $0 of $ISCO
Post-Transaction Position: 30,000 shares
SEC Accession No: 0001683168-26-005073 (CIK: 1182615)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.